V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260014398 | 260009734 | 1.8 | 80.3 | Palliative (P) | 2014-05-25 | 2014-05-25 | Paclitaxel Priming | N | N | 260029448 | CAPECITABINE + MITOMYCIN + RT |
| 260014399 | 260009737 | 1.88 | null | Curative (C) | 2015-02-18 | 2015-02-18 | DHAP - R | 2 | N | 260029461 | IVE |
| 260014400 | 260009739 | 1.67 | null | Palliative (P) | 2016-03-24 | 2016-04-13 | Doxorubicin + Olaratumab | N | N | 260029464 | DHAP - R |
| 260014401 | 260009739 | 1.76 | 62 | Curative (C) | 2015-09-23 | 2015-09-25 | DHAP - R | 02 | N | 260029464 | REMODL TRIAL |
| 260014402 | 260009741 | 1.56 | 94.1 | Curative (C) | 2018-03-11 | 2018-03-21 | VEDex | N | N | 260029465 | R CODOX M |
| 260014403 | 260009742 | 1.72 | 95.8 | Curative (C) | 2016-08-10 | 2016-08-10 | R-GDP | null | Y | 260029466 | CYTARABINE HD + METHOTREXATE HD |
| 260014404 | 260009745 | 1.62 | 71.6 | Palliative (P) | 2013-08-10 | 2013-08-15 | IVE | 02 | N | 260029477 | GDP |
| 260014405 | 260009748 | 1.81 | 72 | Palliative (P) | 2015-03-06 | 2015-05-01 | CHLORAMBUCIL + DEXAMETHASONE + DEXAMETHASONE + ETOPOSIDE | N | N | 260029478 | CYTARABINE + METHOTREXATE + RITUXIMAB |
| 260014406 | 260009749 | 1.58 | 66.3 | Curative (C) | 2017-02-14 | 2017-02-14 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 260029480 | ESHAP |
| 260014407 | 260009749 | 1.73 | 81.2 | Disease modification (D) | 2018-12-30 | 2019-02-17 | CYCLOPHOSPHAMIDE + MESNA | N | N | 260029480 | IVE |
| 260014408 | 260009749 | 1.59 | 72 | Disease modification (D) | 2016-07-27 | 2016-08-03 | Docetaxel 100mg/m2 (21 day) | 02 | Y | 260029480 | DHAP - R |
| 260014409 | 260009750 | 1.64 | 64 | Curative (C) | 2017-03-24 | 2017-03-25 | CARBOPLATIN + PACLITAXEL | 02 | N | 260029502 | CHOP |
| 260014410 | 260009751 | 1.56 | 55.7 | Curative (C) | 2015-04-16 | 2015-04-17 | CHOP | 02 | N | 260029507 | CAPECITABINE + OXALIPLATIN |
| 260014411 | 260009752 | null | null | Palliative (P) | 2018-11-03 | 2018-11-12 | PIXANTRONE | N | null | 260029507 | METHOTREXATE |
| 260014412 | 260009754 | 1.57 | 73 | Curative (C) | null | 2014-07-12 | Cyclophosphamide High Dose | N | N | 260029509 | DHAP |
| 260014413 | 260018206 | 1.59 | 86.2 | Disease modification (D) | null | 2013-09-20 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 2 | N | 260029510 | CARBOPLATIN + PACLITAXEL |
| 260014414 | 260018206 | 1.63 | 63.4 | Adjuvant (A) | 2018-02-21 | 2018-02-24 | R GDP | N | N | 260029510 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260014415 | 260018206 | 1.72 | null | Curative (C) | 2017-07-21 | 2017-10-30 | Abiraterone | N | N | 260029510 | GEMCITABINE + PACLITAXEL |
| 260014416 | 260009757 | 1.69 | 65.4 | Curative (C) | 2016-11-21 | 2016-11-24 | IVE | 2 | N | 260029513 | BEAM R |
| 260014417 | 260009757 | 1.66 | 69 | Curative (C) | 2014-03-24 | 2014-03-31 | Methotrexate High Dose (3g/m2) | 2 | N | 260029513 | LENALIDOMIDE |
| 260014418 | 260009759 | 1.71 | 71.1 | Curative (C) | 2014-04-04 | 2014-04-05 | IDELALISIB | 2 | N | 260029515 | CHLORAMBUCIL |
| 260014419 | 260009760 | 1.82 | 93.7 | Disease modification (D) | 2015-01-11 | 2015-01-15 | BEAM + Alemtuzumab Allo SCT | N | N | 260029518 | CYTARABINE + OXALIPLATIN |
| 260014420 | 260009760 | null | 77 | Neo-adjuvant (N) | 2014-10-22 | 2014-11-19 | CYCLOPHOSPHAMIDE | N | N | 260029518 | CHLORAMBUCIL + RITUXIMAB |
| 260014421 | 260009761 | 1.8 | 120.8 | Palliative (P) | 2015-11-09 | 2015-11-09 | Methotrexate High Dose (3g/m2) | N | N | 260029525 | METHOTREXATE HIGH DOSE |
| 260014422 | 260009763 | 1.9 | 91.5 | Curative (C) | 2015-08-22 | 2015-08-29 | Capecitabine | 02 | null | 260029528 | GDP |
| 260014423 | 260009766 | 1.7 | 51.8 | Curative (C) | 2018-05-26 | 2018-05-26 | GDP | 2 | N | 260029529 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014424 | 260014642 | null | null | null | 2016-03-24 | 2016-03-24 | GDP | N | N | 260029530 | IDARAM |
| 260014425 | 260009767 | 1.78 | 89.7 | null | 2019-07-04 | 2019-07-08 | DA-EPOCH-R | N | N | 260029532 | GDP |
| 260014426 | 260018207 | null | 61.2 | Curative (C) | 2015-12-07 | 2015-12-09 | Cytarabine High Dose | N | null | 260029535 | CISPLATIN + PACLITAXEL |
| 260014427 | 260014645 | 1.68 | 75.6 | Curative (C) | 2017-08-30 | 2017-08-30 | Capecitabine + Cisplatin | 2 | N | 260029535 | IRINOTECAN + MDG |
| 260014428 | 260009774 | 1.86 | 91 | Curative (C) | 2014-05-31 | 2014-05-31 | Doxorubicin 75mg/m2 | 2 | N | 260029546 | IVE |
| 260014429 | 260009774 | 1.62 | null | Disease modification (D) | 2018-02-15 | 2018-04-28 | Docetaxel + Trastuzumab (Maint) | 02 | N | 260029546 | TRASTUZUMAB |
| 260014430 | 260009774 | 1.75 | 87.1 | Curative (C) | 2017-06-02 | 2017-06-02 | GEM-P | 2 | N | 260029546 | IVE |
| 260014431 | 260009775 | null | null | Palliative (P) | null | 2016-08-03 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 260029557 | OXALIPLATIN + MDG |
| 260014432 | 260009776 | 1.72 | 71.4 | Palliative (P) | 2019-01-28 | 2019-01-30 | Bortezomib + Cyclophos + Dex | N | N | 260029560 | IBRUTINIB |
| 260014433 | 260009777 | null | 77 | Disease modification (D) | 2015-03-24 | 2015-04-13 | DHAP - R | N | N | 260029565 | LENALIDOMIDE |
| 260014434 | 260009778 | null | 65.7 | Curative (C) | 2016-07-04 | 2016-08-03 | ACE (germ cell) | N | N | 260029566 | TEMOZOLOMIDE |
| 260014435 | 260009779 | 1.63 | 61.7 | Curative (C) | 2013-12-13 | 2013-12-25 | TRASTUZUMAB | N | null | 260029566 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014436 | 260017023 | 1.76 | 82 | Curative (C) | 2018-02-07 | 2018-03-05 | Imatinib 400mg | N | N | 260029568 | METHOTREXATE |
| 260014437 | 260009781 | 0 | null | Curative (C) | 2015-05-08 | 2015-05-11 | ECX | N | null | 260029570 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014438 | 260009782 | 1.69 | 62 | Curative (C) | 2018-01-27 | 2018-01-27 | Fluorouracil+Mitomycin+RT (Bladder) | 2 | N | 260029571 | PAC-PLAT |
| 260014439 | 260009784 | 1.65 | 83.6 | Disease modification (D) | 2017-10-20 | 2017-10-22 | Capecitabine (21days) + Carboplatin | 2 | N | 260029571 | METHOTREXATE HIGH DOSE |
| 260014440 | 260009784 | 1.53 | 72 | Curative (C) | 2017-02-17 | 2017-03-09 | Cytarabine intrathecal | 2 | N | 260029571 | GDP |
| 260014441 | 260009785 | 1.62 | null | Curative (C) | 2017-04-23 | 2017-04-26 | CYCLOPHOSPHAMIDE | N | null | 260029587 | PIXANTRONE |
| 260014442 | 260009786 | 1.82 | 94.6 | Curative (C) | 2019-04-06 | 2019-06-29 | Docetaxel + Gemcitabine (prior RT) | N | N | 260029592 | EP |
| 260014443 | 260009787 | 1.78 | 93.1 | Palliative (P) | 2017-03-03 | 2017-03-11 | GEMCITABINE + OXALIPLATIN + PACLITAXEL | 02 | N | 260029593 | METHOTREXATE |
| 260014444 | 260009787 | 1.6 | 55.6 | Disease modification (D) | 2015-02-13 | 2015-02-20 | RCEOP | N | N | 260029593 | GEMCITABINE + PACLITAXEL |
| 260014445 | 260009787 | 1.69 | null | Palliative (P) | 2017-02-22 | 2017-02-24 | EP | N | N | 260029593 | BRENTUXIMAB |
| 260014446 | 260009790 | 1.63 | 79.5 | Palliative (P) | 2018-01-02 | 2018-02-23 | IVE | N | N | 260029604 | METHOTREXATE HIGH DOSE |
| 260014447 | 260014653 | 1.79 | 80.2 | Not known (9) | 2019-02-05 | 2019-02-16 | CISPLATIN + GEMCITABINE | N | N | 260029604 | GEMCITABINE + OXALIPLATIN |